GemVax & KAEL (South Korea)

The novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase

Hyun‐Hee Park, Kyu‐Yong Lee, Sangjae Kim et al. · Neurobiology of Aging · 2014 · 71 citations

Life Sciences, Immunology, Molecular Biology +16

Serum neurofilament light chain level as a predictor of cognitive stage transition

Eun Hye Lee, Hyuk Sung Kwon, Seong‐Ho Koh et al. · Alzheimer s Research & Therapy · 2022 · 60 citations · Full text

Medicine, Neurology, Neuroscience +17

Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals

Hyun-Hee Park, Hyun-Jung Yu, Sangjae Kim et al. · NeuroToxicology · 2016 · 48 citations

Life Sciences, Neurobiology, Neuroscience +13

Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial

Jung Hyun Jo, Yong‐Tae Kim, Ho Soon Choi et al. · British Journal of Cancer · 2023 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Relationship between telomere shortening and age in Korean individuals with mild cognitive impairment and Alzheimer’s disease compared to that in healthy controls

Eun-Hye Lee, Myung‐Hoon Han, Jungsoon Ha et al. · Aging · 2020 · 22 citations · Full text

Medicine, Neurology, Neuroscience +17